Value Management Office (VMO) — MedTech & Life Sciences Portfolio
About the position
The Value Management Office (VMO) is a senior leadership role focused on driving value creation within Graham Partners’ healthcare, medtech, and life sciences portfolio. This role is responsible for translating investment theses into measurable financial and enterprise value outcomes. The VMO establishes the strategic operating rhythm that connects deal-thesis priorities to execution and benefits realization, ensuring portfolio companies operate with the necessary speed and discipline. The role operates at the intersection of strategy and operations, partnering directly with portfolio company CEOs and Chief Transformation Officers to develop value-creation roadmaps, business cases, and transformation agendas, while accelerating commercial and operational execution. Key challenges addressed include FDA and quality-system readiness (21 CFR 820, ISO 13485, ISO 9001), customer audits, complaint/CAPA performance, OEM customer concentration, manufacturing scale-up, supplier risk, and M&A integration. The VMO collaborates with Graham Partners’ (GPOC) functional teams (Finance, Operations, Technology & AI, ESG & Compliance) and acts as a central hub connecting investment teams, portfolio leadership, and external advisors.
Responsibilities
- Translate investment theses into value-creation plans, converting deal-thesis priorities into prioritized, sequenced, and resourced value-creation roadmaps that reflect CDMO and regulated-manufacturing operating environments.
- Institutionalize value-creation discipline across the portfolio by establishing and scaling a portfolio-wide operating system (governance, KPIs, integrated roadmaps) across priority portfolio companies.
- Drive execution by ensuring priority initiatives have accountable owners, defined KPIs, milestone-based plans, and disciplined performance reviews tied to value capture.
- Surface the portfolio view by building and maintaining integrated, cross-initiative roadmaps that expose interdependencies, constraints, and capital needs.
- Make value visible by delivering board-ready dashboards and Investment Committee narratives that translate operating progress into enterprise-value language.
- Architect the VMO operating model, including steering committees, working sessions, escalation paths, and decision rights.
- Define the operating playbook used across the healthcare portfolio.
- Partner with portfolio company leadership and GPOC operating partners to scope high-impact initiatives across commercial growth, operational excellence, quality and regulatory readiness, manufacturing scale-up, supply chain, and digital/AI transformation.
- Consolidate initiatives into an integrated portfolio view with clear sequencing and capital implications.
- Own the value-tracking framework end-to-end: baseline definition, KPI design, value attribution, and outcome reporting.
- Hold initiative owners accountable for outcomes at both the portfolio company and portfolio level.
- Identify cross-functional risks early, particularly those unique to CDMOs serving regulated end markets, and drive structured mitigation and decision paths.
- Support add-on integrations and carve-outs by embedding VMO discipline into Day 1 and 100-day plans, focusing on integrating quality systems, regulatory filings, and commercial/operations functions.
- Lead deployment and adoption of GPOC’s PMO platform (Conductor) and value-management standards across portfolio companies.
- Coach portfolio company leadership teams on operating mechanisms, performance cadences, and value-creation best practices.
- Operate as a trusted advisor to portfolio company CEOs and Chief Transformation Officers, partnering with Chief Operating Officers, Chief Commercial Officers, and the Finance Value Creation team.
- Align deal teams, functional operating partners, and external advisors around a shared agenda and outcome-oriented communication.
- Work with each portfolio company’s transformation leader to embed operating cadence, measure impact, escalate issues, and ensure value-creation plans remain dynamic.
Requirements
- CDMO, contract manufacturing, or life sciences depth with direct experience driving value creation, transformation, or operating leadership within regulated manufacturing businesses serving OEM customers.
- Working familiarity with FDA regulatory pathways and quality systems (21 CFR 820, ISO 13485, ISO 9001), customer audit dynamics, and OEM commercial relationships is strongly preferred.
- 10+ years driving complex, cross-functional value creation.
- Background in top-tier strategy consulting, PE operations, or enterprise transformation leadership.
- Track record of aligning strategy, capital, and execution across multiple programs or business units.
- Demonstrated success standing up VMO/PMO operating systems, KPI architectures, and portfolio-management tooling across multiple companies or business units.
- Strong command of EBITDA bridges, value-creation modeling, business-case quantification, and executive-ready reporting.
- Comfortable interrogating operating KPIs and commercial metrics with portfolio company leadership and Operating Partners.
- High EQ and proven ability to earn trust and drive action with C-suite leaders, founder-led management teams, deal partners, and functional experts—often without direct authority.
- Operates with intellectual honesty, willingness to challenge sacred cows, reset plans, and hold the line on accountability.
Nice-to-haves
- Experience with Conductor (primary PMO and portfolio tool).
Benefits
- Comprehensive health benefits package, including medical, dental, and vision
- 401(k)
- Opportunity for a hybrid office schedule
- Paid firmwide holidays
- Ongoing training
- Wellness stipend / Fitler Club membership
- Paid parental leave